<DOC>
	<DOCNO>NCT01009541</DOCNO>
	<brief_summary>The purpose study 1 ) evaluate extent absorption multiple dos three pregabalin control release tablet compare multiple dos pregabalin immediate release capsule , 2 ) evaluate pharmacokinetics multiple dos three pregabalin control release tablet compare multiple dos pregabalin immediate release capsule 3 ) evaluate safety tolerability multiple dos three pregabalin control release tablet compare multiple dos pregabalin immediate release capsule .</brief_summary>
	<brief_title>An Investigation Absorption Pharmacokinetics Multiple Doses Three Controlled Release Pregabalin Tablets Compared Multiple Doses Immediate Release Pregabalin Capsule</brief_title>
	<detailed_description />
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Healthy male female Between age 18 55 year , inclusive Body Mass Index ( BMI ) 17.5 30.5 kg/m2 Illicit drug use Pregnant nursing female Females childbearing potential unwilling unable use acceptable method contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>pregabalin pharmacokinetics bioavailability bioequivalence</keyword>
</DOC>